The IXORA trial is a head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis. Watch the video to find out the summary of the IXORA trial results!
IXORA trial: Comparison Between Ixekizumab and Guselkumab for Plaque Psoriasis
By Sian Lin
Sian Lin
This writer is part of the Medical Channel Asia editorial team. The Medical Channel Asia editorial team brings together a diverse group of seasoned journalists, pharmacists, and doctor to deliver breaking news, insightful analysis, informed opinions, and thought-provoking perspectives into the world of healthcare.
